Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Personal

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT (Bifunctional SuperKine for ImmunoTherapy), engineered to deliver an anti-PD1-IL-2 Superkine (anti-PD1-IL-2SK) to the tumor microenvironment (TME), where it is conditionally activated

By: financialpost.com

Nov 08 2024
0
0 Views

Related

Johannesburg Lashes Out at Eskom for Threatening to Halt Power

China launches $1.4 trillion plan to bail out local governments

Brookfield Property Partners Declares Quarterly Dividends on Listed Preferred Units

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Inflation Jumps in Brazil, Chile in Challenge for Central Banks

Burford Capital Open to Argentine Bonds for $16 Billion Judgment

Federal government faces potential loss if Trans Mountain pipeline sold: PBO

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

Backblaze Announces Record Adjusted EBITDA Margin as Part of Third Quarter 2024 Financial Results

Canada Weak Job Gains Keep Bigger December Cut a Toss-Up

Western Uranium & Vanadium Corp. Announces Brokered Financing Up to CAD $5.5 Million

VERSES Provides Update on Private Placement

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Johannesburg Lashes Out at Eskom for Threatening to Halt Power